Eiad Habib, Ramzi Ibrahim, Hoang Nhat Pham, Mahmoud Abdelnabi, Christopher Kanaan, Abdulrhman Eldeib et al. Finerenone Versus Spironolactone for Heart Failure with Preserved Ejection Fraction. // Cardiovascular Drugs and Therapy. – 2025. – DOI: 10.1007/s10557-025-07822-x. – URL: https://doi.org/10.1007/s10557-025-07822-x
Eiad Habib, Ramzi Ibrahim, Hoang Nhat Pham, Mahmoud Abdelnabi, Christopher Kanaan, Abdulrhman Eldeib, Silvio Nunes Augusto, Chadi Ayoub, W. H. Wilson Tang, & Reza Arsanjani (2025). Finerenone Versus Spironolactone for Heart Failure with Preserved Ejection Fraction. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07822-x
Eiad Habib, et al. “Finerenone Versus Spironolactone for Heart Failure with Preserved Ejection Fraction.” Cardiovascular Drugs and Therapy, 2025. doi:10.1007/s10557-025-07822-x.
@article{Habib2025,
title = {Finerenone Versus Spironolactone for Heart Failure with Preserved Ejection Fraction},
author = {Habib, Eiad and Ibrahim, Ramzi and Pham, Hoang Nhat and Abdelnabi, Mahmoud and Kanaan, Christopher and Eldeib, Abdulrhman and Augusto, Silvio Nunes and Ayoub, Chadi and Tang, W. H. Wilson and Arsanjani, Reza},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
doi = {10.1007/s10557-025-07822-x},
url = {https://doi.org/10.1007/s10557-025-07822-x}
}